Violetta Cotreau
Nessuna posizione attualmente
Storia della carriera di Violetta Cotreau
Precedenti posizioni note di Violetta Cotreau
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/12/2020 | 30/12/2022 |
| Corporate Officer/Principal | 30/12/2022 | 30/12/2022 | |
| AMAG PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/12/2016 | 01/11/2020 |
Formazione di Violetta Cotreau
| University of Massachusetts Lowell | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
Posizioni
| Comptroller/Controller/Auditor | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Violetta Cotreau
- Esperienza
